Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Adjuvant Radioimmunotherapy Compared With Adjuvant Chemotherapy for Upper Tract Urothelial Carcinoma: An Ambispective Cohort Study

NCT06120374 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.

NCT NCT06120374
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06120374 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Adjuvant Radioimmunotherapy Compared With Adjuvant Chemotherapy for Upper Tract Urothelial Carcinoma: An Ambispective Cohort Study
Lead sponsor
Peking University First Hospital
Phase
Observational
Overall status
Recruiting
Start date
January 1, 2022
Completion date
June 8, 2029
Enrollment
178 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

urothelial carcinoma